首页> 外文期刊>Circulation journal >Relationships of Elevated Systemic Pentraxin-3 Levels With High-Risk Coronary Plaque Components and Impaired Myocardial Perfusion After Percutaneous Coronary Intervention in Patients With ST-Elevation Acute Myocardial Infarction
【24h】

Relationships of Elevated Systemic Pentraxin-3 Levels With High-Risk Coronary Plaque Components and Impaired Myocardial Perfusion After Percutaneous Coronary Intervention in Patients With ST-Elevation Acute Myocardial Infarction

机译:高风险冠状动脉斑块组分的高危冠状动脉斑块升高的升高冠状动脉斑块组分的关系,经皮冠状动脉干预后心肌干预后心肌灌注受损急性心肌梗死

获取原文
获取外文期刊封面目录资料

摘要

Background: ?We aimed to assess the relationships of pentraxin-3 (PTX3) with coronary plaque components and myocardial perfusion after percutaneous coronary intervention (PCI) in order to clarify the mechanisms underlying the prognostic function of PTX3 in ST-elevation acute myocardial infarction (STEMI) patients. Methods and Results: ?We enrolled 75 STEMI patients who underwent pre-PCI virtual histology (VH)-intravascular ultrasound. Relationships of the systemic pre-PCI PTX3 level with coronary plaque components and post-PCI myocardial blush grade (MBG) were evaluated. Lesions with elevated pre-PCI PTX3 (median ≥3.79ng/ml) had higher frequencies of VH-derived thin-cap fibroatheroma (65.8% vs. 24.3%, P2=8.6; P=0.003). Cox proportional-hazards analysis showed post-PCI MBG (0–1) (hazard ratio, 4.109; 95% CI, 1.372–12.309; P=0.012) and Killip class >2 on admission (hazard ratio, 5.356; 95% CI, 1.409–20.359; P=0.014) as independent predictors of adverse cardiac events during follow-up. Conclusions: ?Systemic pre-PCI PTX3 was associated with high-risk plaque components and impaired post-PCI myocardial perfusion. Thus, PTX3 may be a reliable predictor of outcome in STEMI patients.??( Circ J ?2014; 78: 159–169)
机译:背景:旨在评估Pentraxin-3(PTX3)与经皮冠状动脉干预(PCI)后心肌灌注的关系的关系,以澄清PTX3在ST升高急性心肌梗死中的预后功能下面的机制( stemi)患者。方法和结果:我们注册了75名患有PRE-PCI虚拟组织学(VH) - 跨越血管超声的患者。评估了全身前PCI PTX3水平与冠状动脉斑块组分和PCI后心肌腮红级(MBG)的关系。具有升高的PCI PTX3(中位数≥3.79ng/ ml)的病变具有较高的VH衍生的薄帽纤维瘤频率(65.8%与24.3%,P2 = 8.6; p = 0.003)。 COX比例危害分析显示PCI MBG(0-1)(危险比,4.109; 95%CI,1.372-12.309; P = 0.012)和Killip类> 2关于入场(危险比,5.356; 95%CI, 1.409-20.359; p = 0.014)作为随访期间不利心脏事件的独立预测因子。结论:系统预科PTX3与高风险斑块组分相关,后PCI后心肌灌注有关。因此,PTX3可以是STEMI患者结果的可靠预测因子。??(酷J?2014; 78:159-169)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号